1
|
Ng ML, Majid AMSA, Yee SM, Natesan V, Basheer MKA, Gnanasekaran A, Al-Suede FSR, Parish C, Dalal M, Ming LC, Nazari V M, Khan SS, Stn Hameed Sultan SB, Babu KG, Majid ASA, Abdul Aziz MAS. A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors. Support Care Cancer 2024; 32:331. [PMID: 38710920 DOI: 10.1007/s00520-024-08536-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2023] [Accepted: 04/30/2024] [Indexed: 05/08/2024]
Abstract
AIM We evaluated the efficacy and safety of Nuvastatic™ (C5OSEW5050ESA) in improving cancer-related fatigue (CRF) among cancer patients. METHODS This multicenter randomized double-blind placebo-controlled phase 2 trial included 110 solid malignant tumor patients (stage II-IV) undergoing chemotherapy. They were randomly selected and provided oral Nuvastatic™ 1000 mg (N = 56) or placebo (N = 54) thrice daily for 9 weeks. The primary outcomes were fatigue (Brief Fatigue Inventory (BFI)) and Visual Analog Scale for Fatigue (VAS-F)) scores measured before and after intervention at baseline and weeks 3, 6, and 9. The secondary outcomes were mean group difference in the vitality subscale of the Medical Outcome Scale Short Form-36 (SF-36) and urinary F2-isoprostane concentration (an oxidative stress biomarker), Eastern Cooperative Oncology Group scores, adverse events, and biochemical and hematologic parameters. Analysis was performed by intention-to-treat (ITT). Primary and secondary outcomes were assessed by two-way repeated-measures analysis of variance (mixed ANOVA). RESULTS The Nuvastatic™ group exhibited an overall decreased fatigue score compared with the placebo group. Compared with the placebo group, the Nuvastatic™ group significantly reduced BFI-fatigue (BFI fatigue score, F (1.4, 147) = 16.554, p < 0.001, partial η2 = 0.333). The Nuvastatic™ group significantly reduced VAS-F fatigue (F (2, 210) = 9.534, p < 0.001, partial η2 = 0.083), improved quality of life (QoL) (F (1.2, 127.48) = 34.07, p < 0.001, partial η2 = 0.243), and lowered urinary F2-IsoP concentrations (mean difference (95% CI) = 55.57 (24.84, 86.30)), t (55) = 3.624, p < 0.001, Cohen's d (95% CI) = 0.48 (0.20, 0.75)). Reported adverse events were vomiting (0.9%), fever (5.4%), and headache (2.7%). CONCLUSION Nuvastatic™ is potentially an effective adjuvant for CRF management in solid tumor patients and worthy of further investigation in larger trials. TRIAL REGISTRATION ClinicalTrial.gov ID: NCT04546607. Study registration date (first submitted): 11-05-2020.
Collapse
Grants
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
- KP/ITTP/S/1/367-1 Jld.2 (91) The Malaysian Ministry of Agriculture, Malaysia
Collapse
Affiliation(s)
- Mei Ling Ng
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | - Amin Malik Shah Abdul Majid
- EMAN Research Ltd, Symonston, Australia
- College of Health & Medicine, Australian National University, Canberra, Australia
| | - Siew Mei Yee
- Faculty of Pharmacy, SEGi University, Petaling Jaya, Malaysia
| | - V Natesan
- EMAN Research Ltd, Symonston, Australia
| | | | - Ashok Gnanasekaran
- Department of Pharmacology, Faculty of Medicine, Quest International University, Ipoh, Malaysia
| | | | - Christopher Parish
- College of Health & Medicine, Australian National University, Canberra, Australia
| | - Meena Dalal
- Notrox Research Private Limited, Hospital & Health Care Bangalore, Bangalore, Karnataka, India
| | - Long Chiau Ming
- School of Medical and Life Sciences, Sunway University, Sunway City, Malaysia
| | - Mansoureh Nazari V
- EMAN Biodiscoveries Sdn. Bhd, Sungai Petani, Malaysia
- School of Pharmacy, Universitas 17 Agustus 1945 Jakarta, Jakarta, Indonesia
| | | | - Siti Balkees Stn Hameed Sultan
- EMAN Biodiscoveries Sdn. Bhd, Sungai Petani, Malaysia
- Integrative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala Batas, Penang, Malaysia
| | - K Govind Babu
- HCG Cancer Centre-Double Road, Bengaluru, Karnataka, India
| | - Aman Shah Abdul Majid
- Department of Pharmacology, Faculty of Medicine, Quest International University, Ipoh, Malaysia.
- EMAN Biodiscoveries Sdn. Bhd, Sungai Petani, Malaysia.
| | | |
Collapse
|
2
|
V MN, Mahmood S, Shah AM, Al-Suede FSR. Suppression of Melanoma Growth in a Murine Tumour Model Using Orthosiphon stamineus Benth. Extract Loaded in Ethanolic Phospholipid Vesicles (Spherosome. Curr Drug Metab 2022; 23:317-328. [PMID: 35430963 DOI: 10.2174/1389200223666220416215129] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2021] [Revised: 02/17/2022] [Accepted: 03/01/2022] [Indexed: 11/22/2022]
Abstract
BACKGROUND Orthosiphon stamineus Benth (O.S) is a traditional south-east Asian herb. The extract of O.S is used in the formulation of ethanolic nanolipid vesicle system to have considerable potential for tumour therapeutics. METHOD The research objective is to develop and characterise the anticancer and antiangiogenic effect of O.S extract in the form of nano-ethanolic spherosomes (ESP) using phospholipids in melanoma. Spherosomes formulation of O.S was developed using the thin-film re-hydration method and converted to gel using Acrypol 1%. The formulations were subjected to optimisation and physical-chemical characterisations like particle size, surface charge, DSC, FTIR, TEM. Cytotoxicity of O.S and ESP were studied using an endothelial cell line (EA. hy926). Furthermore, anti-melanoma effect of O.S spherosome gel was studied in albino mice after topical administration. RESULTS ESP-6 with the ratio of extract (O.S): cholesterol: phospholipid (1: 6: 0.5) showed the highest entrapment efficiency (80.56 ± 0.84%) using ultraviolet spectroscopy. In-vivo permeation/penetration studies revealed deeper absorption of ESP-6 compared with a hydroethanolic gel of O.S. In-vitro and in vivo anti-melanoma studies demonstrated the significant tumour-suppressing effect of ESP-6 on murine melanoma. Percentage inhibition of tumour growth by O.S and ESP-6 at 3000 mg/kg showed 63.98 ± 7.86% and 87.76 ± 7.90%, respectively. CONCLUSION Spherosome vesicles were developed with a smooth surface. The results demonstrated that O.S extract showed no toxicity when tested on the endothelial cell line. O.S loaded in spherosomes has the potential to lower the growth of melanoma in mice. The spherosomes loaded with O.S do not promote tumour growth or act as antiangiogenetic in melanoma.
Collapse
Affiliation(s)
- Mansoureh Nazari V
- Universitas Augustus 17, 1945,14350 Jakarta.,School of pharmaceutical sciences, Universiti Sains Malaysia, Minden
| | | | | | | |
Collapse
|
3
|
Mojiri A, Zhou JL, Ratnaweera H, Rezania S, Nazari V M. Pharmaceuticals and personal care products in aquatic environments and their removal by algae-based systems. Chemosphere 2022; 288:132580. [PMID: 34687686 DOI: 10.1016/j.chemosphere.2021.132580] [Citation(s) in RCA: 26] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Revised: 10/04/2021] [Accepted: 10/13/2021] [Indexed: 06/13/2023]
Abstract
The consumption of pharmaceuticals and personal care products (PPCPs) has been widely increasing, yet up to 90-95% of PPCPs consumed by human are excreted unmetabolized. Moreover, the most of PPCPs cannot be fully removed by wastewater treatment plants (WWTPs), which release PPCPs to natural water bodies, affecting aquatic ecosystems and potentially humans. This study sought to review the occurrence of PPCPs in natural water bodies globally, and assess the effects of important factors on the fluxes of pollutants into receiving waterways. The highest ibuprofen concentration (3738 ng/L) in tap water was reported in Nigeria, and the highest naproxen concentration (37,700 ng/L) was reported in groundwater wells in Penn State, USA. Moreover, the PPCPs have affected aquatic organisms such as fish. For instance, up to 24.4 × 103 ng/g of atenolol was detected in P. lineatus. Amongst different technologies to eliminate PPCPs, algae-based systems are environmentally friendly and effective because of the photosynthetic ability of algae to absorb CO2 and their flexibility to grow in different wastewater. Up to 99% of triclosan and less than 10% of trimethoprim were removed by Nannochloris sp., green algae. Moreover, variable concentrations of PPCPs might adversely affect the growth and production of algae. The exposure of algae to high concentrations of PPCPs can reduce the content of chlorophyll and protein due to producing reactive oxygen species (ROS), and affecting expression of some genes in chlorophyll (rbcL, psbA, psaB and psbc).
Collapse
Affiliation(s)
- Amin Mojiri
- Faculty of Sciences and Technology, Norwegian University of Life Sciences, 1430, Ås, Norway; Department of Civil and Environmental Engineering, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-4-1 Kagamiyama, Higashihiroshima, 739-8527, Japan.
| | - John L Zhou
- School of Civil and Environmental Engineering, University of Technology Sydney, Sydney, NSW, 2007, Australia.
| | - Harsha Ratnaweera
- Faculty of Sciences and Technology, Norwegian University of Life Sciences, 1430, Ås, Norway
| | - Shahabaldin Rezania
- Department of Environment and Energy, Sejong University, Seoul, 05006, South Korea
| | - Mansoureh Nazari V
- School of Pharmacy, University of 17 August 1945, Jakarta, 14350, Indonesia
| |
Collapse
|
4
|
Hayat K, Tariq U, Wong QA, Quah CK, Majid ASA, Nazari V M, Ahamed MBK, Iqbal MA, Tirmizi SA. Green synthesis of selenium based N-heterocyclic carbene compounds; structural, in-vitro anticancer and molecular docking studies. Comput Biol Chem 2021; 94:107567. [PMID: 34500323 DOI: 10.1016/j.compbiolchem.2021.107567] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Revised: 06/24/2021] [Accepted: 08/21/2021] [Indexed: 01/06/2023]
Abstract
Benzimidazolium salts (3-6) were synthesized as stable N-Heterocyclic Carbene (NHC) precursors and their selenium-NHC compounds/Selenones (7-10) were prepared using water as a solvent. Characterization of each of the synthesized compounds was carried out by various analytical and spectroscopic (FT-IR, 1H-, 13C NMR) methods. X-ray crystallographic analyses of single crystals obtained for salts 3 and 5 were carried out. Synthesized salts and their Se-NHCs were tested in-vitro for their anticancer potential against Cervical Cancer Cell line from Henrietta Lacks (HeLa), Breast cancer cell line (MDA-MB-231), Adenocarcinoma cell line (A549) and human normal endothelial cell line (EA.hy926). MTT assay was used for analysis and compared with standard drug 5-flourouracil. Benzimidazolium salts (3-6) and their selenium counter parts (7-10) were found potent anticancer agents. Salt 3-5 were found to be potent anticancer against HeLa with IC50 values 0.072, 0.017 and 0.241 μM, respectively, which are less than standard drug (4.9 μM). The Se-NHCs (7-10) had also shown significant anticancer potential against HeLa with IC50 values less than standard drug. Salts 3, 4 against EA.hy926, compounds 3,5,6, and 10 against MDA-MB-321, and compounds 4, 10 against A-549 cell line were found more potent anticancer agents with IC50 values less than standard drug. Molecular docking for (7-10) showed their good anti-angiogenic potential having low binding energy and significant inhibition constant values with VEGFA (vascular endothelial growth factor), EGF (human epidermal growth factor), COX1 (cyclooxygenase-1) and HIF (hypoxia inducible factor).
Collapse
Affiliation(s)
- Khizar Hayat
- Department of Chemistry, Quaid-I-Azam University, Islamabad 45320, Pakistan; Department of Chemistry, Government P/G College of Science, Faisalabad 38000, Pakistan
| | - Umaira Tariq
- Department of Chemistry, The Minhaj University, Lahore 54770, Pakistan
| | - Qin Ai Wong
- X-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, Penang 11800, Malaysia
| | - Ching Kheng Quah
- X-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, Penang 11800, Malaysia
| | | | - Mansoureh Nazari V
- Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden 11800, Pulau Penang, Malaysia; School of Pharmacy, University August 17, 1945 14350 Jakarta, Indonesia
| | - Mohamed B Khadeer Ahamed
- EMAN Biodiscoveries Sdn. Bhd., A1-4, Lot 5, Persiaran 2/1, Kedah Halal Park, Kawasan Perindustrian Sungai Petani, 08000 Sungai Petani, Kedah, Malaysia
| | - Muhammad Adnan Iqbal
- Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan; Organometallic and Coordination Chemistry Laboratory, Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
| | - Syed Ahmed Tirmizi
- Department of Chemistry, Quaid-I-Azam University, Islamabad 45320, Pakistan.
| |
Collapse
|
5
|
Kamal A, Nazari V M, Yaseen M, Iqbal MA, Ahamed MBK, Majid ASA, Bhatti HN. Green synthesis of selenium-N-heterocyclic carbene compounds: Evaluation of antimicrobial and anticancer potential. Bioorg Chem 2019; 90:103042. [PMID: 31226469 DOI: 10.1016/j.bioorg.2019.103042] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Revised: 05/22/2019] [Accepted: 06/03/2019] [Indexed: 12/11/2022]
Abstract
Three benzimidazolium salts (III-V) and respective selenium adducts (VI-VIII) were designed, synthesized and characterized by various analytical techniques (FT-IR and NMR 1H, 13C). Selected salts and respective selenium N-Heterocyclic carbenes (selenium-NHC) adducts were tested in vitro against Cervical Cancer Cell line (Hela), Breast Adenocarcinoma cell line (MCF-7), Retinal Ganglion Cell line (RGC-5) and Mouse Melanoma Cell line (B16F10) using MTT assay and the results were compared with standard drug 5-Fluorouracil. Se-NHC compounds and azolium salts showed significant anticancer potential. Molecular docking studies of compounds (VI, VII and VIII) showed strong binding energies and ligand affinity toward following angiogenic factors: VEGF-A (vascular endothelial growth factor A), EGF (human epidermal growth factor), HIF (Hypoxia-inducible factor) and COX-1 (Cyclooxygenase-1) suggesting that the anticancer activity of adducts (VI, VII and VIII) may be due to their strong anti-angiogenic effect. In addition, compounds III-VIII were screened for their antibacterial and antifungal potential. Adduct VI was found to be potent anti-fungal agent against A. Niger with zone of inhibition (ZI) value 27.01 ± 0.251 mm which is better than standard drug Clotrimazole tested in parallel.
Collapse
Affiliation(s)
- Amna Kamal
- Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan
| | - Mansoureh Nazari V
- Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, 11800 Pulau Penang, Malaysia
| | - Muhammad Yaseen
- Department of Chemistry, University of Education (Lahore), Faisalabad Campus, Faisalabad, Pakistan
| | - Muhammad Adnan Iqbal
- Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan; Organometallic and Coordination Chemistry Laboratory, Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
| | - Mohamed B Khadeer Ahamed
- EMAN Biodiscoveries Sdn. Bhd., A1-4, Lot 5, Persiaran 2/1, Kedah Halal Park, Kawasan Perindustrian Sungai Petani, 08000 Sungai Petani, Kedah, Malaysia
| | | | - Haq Nawaz Bhatti
- Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
| |
Collapse
|